References

Daimon, M., S. Aomi, T. Kawamata and H. Kurosawa, 2004. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus. Neurosci. Lett., 362: 122-126.
CrossRef  |  

Dantas, A.C., L.F. Macedo, M.N. Mendes, I.M. Azevedo and A.C. Medeiros, 2010. Protective effect of simvastatin in the cyclophosphamide-induced hemorrhagic cystitis in rats. Acta Cir Bras., 25: 43-46.
Direct Link  |  

Dinarello, C.A., 2010. Anti-inflammatory agents: Present and future. Cell, 140: 935-950.
CrossRef  |  

Endres, M., U. Laufs, Z. Huang, T. Nakamura, P. Huang, M.A. Moskowitz and J.K. Liao, 1998. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Nat. Acad. Sci., 95: 8880-8885.
Direct Link  |  

Goncalves, D.O., I.B.F. Calou, R.P. Siqueira, A.A. Lopes and L.K.A. Leal et al., 2011. In vivo and In vitro anti-inflammatory and anti-nociceptive activities of lovastatin in rodents. Braz. J. Med. Biol. Res., 44: 173-181.

Kirsch, C., G.P. Eckert, A.R. Koudinov and W.E. Muller, 2003. Brain cholesterol, statins and alzheimer's disease. Pharmacopsychiatry, 36: S113-S119.
PubMed  |  

Lee, J.K., J.S. Won, A.K. Singh and I. Singh, 2008. Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death. Neurosci. Lett., 440: 260-264.
CrossRef  |  

Lu, D., A. Goussev, J. Chen, P. Pannu, Y. Li, A. Mahmood and M. Chopp, 2004. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis and neuronal survival in rats subjected to traumatic brain injury. J. Neurotrauma, 21: 21-32.
PubMed  |  

Massaro, M., A. Zampolli, E. Scoditti, M.A. Carluccio, C. Storelli, A. Distante and R. De Caterina, 2010. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: Antiangiogenic actions possibly contributing to plaque stability. Cardiovasc. Res., 86: 311-320.
PubMed  |  

McCarey, D.W., I. McInnes, R. Mahdhok, R. Hampson and O. Scherbakova et al., 2004. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial. Lancet, 363: 2015-2021.
PubMed  |  

McTaggart, F., L. Buckett, R. Davidson, G. Holdgate and A. McCormick et al., 2001. Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Am. J. Cardiol., 87: 28B-32B.
PubMed  |  

Nath, N., S. Giri, R. Prasad, A.K. Singh and I. Singh, 2004. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J. Immunol., 172: 1273-1286.
PubMed  |  

Nezic, L., R. Skrbic, S. Dobric, M.P. Stojiljkovic, S.S. Satara, Z.A. Milovanovic and N. Stojakovic, 2009. Effect of simvastatin on proinflammatory cytokines production during lipopolysaccharide-induced inflammation in rats. Gen. Physiol. Biophys., 28: 119-126.
PubMed  |  

Paintlia, A.S., M.K. Paintlia, M. Khan, T. Vollmer, A.K. Singh and I. Singh, 2005. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. Fed. Am. Soc. Exp. Biol. J., 19: 1407-1421.
PubMed  |  

Pannu, R., D.K. Christie, E. Barbosa, I. Singh and A.K. Singh, 2007. Post-trauma lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection and promotes locomotor recovery following spinal cord injury. J. Neurochem., 101: 182-200.
CrossRef  |  

Rangel, P., R.M. Cysneiros, R.M. Arida, M. de Albuquerque and D.B. Colugnati et al., 2005. Lovastatin reduced neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: Preliminary results. Arq Neuropsiquiatr., 63: 972-976.
PubMed  |  

Samini, M., H. Shafaroodi, V. Sehat and S. Allahdini, 2005. Comparison of the effects of lindane and permethrin on pentylenetetrazole-induced clonic seizure in mice. Online J. Vet. Res., 9: 37-47.
Direct Link  |  

Scandinavian Simvastatin Survival Study, 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastatin survival study (4S). Lancet, 344: 1383-1389.
Direct Link  |  

Shafaroodi, H., M. Samini, L. Moezi, H. Homayoun and H. Sadeghipour et al., 2004. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology, 47: 390-400.
CrossRef  |  

Shepherd, J., S.M. Cobbe, I. Ford, C.G. Isles and A.R. Lorimer et al., 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med., 333: 1301-1307.
Direct Link  |  

Singh, I., K. Pahan and M. Khan, 1998. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy. FEBS Lett., 426: 342-346.
CrossRef  |  

Sironi, L., M. Cinino, U. Guerrini, A.M. Calvio and B. Lodetti et al., 2003. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol., 23: 322-327.
PubMed  |  

Sparrow, C.P., C.A. Burton, M. Hernandez, S. Mundt and H. Hassing et al., 2001. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler. Thromb. Vasc. Biol., 21: 115-115.

Stanislaus, R., A.G. Gilg, A.K. Singh and I. Singh, 2002. Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin. Neurosci. Lett., 333: 167-170.
CrossRef  |  

Stanislaus, R., A.K. Singh and I. Singh, 2001. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res., 66: 155-162.
CrossRef  |  

Stanislaus, R., K. Pahan, A.K. Singh and I. Singh, 1999. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci. Lett., 269: 71-74.
PubMed  |  

Vollmer, T., L. Key, V. Durkalski, W. Tyor and J. Corboy et al., 2004. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet, 363: 1607-1608.
PubMed  |  

Wang, C.Y., P.Y. Liu and J.K. Liao, 2008. Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results. Trends Mol. Med., 14: 37-44.
CrossRef  |  PubMed  |  Direct Link  |  

Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata and J. Kallen et al., 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med., 7: 687-692.
CrossRef  |